Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis

被引：0
|
作者：
Jianchao Zhang
Junnan Tang
Xiaolin Cui
Bo Wang
Mengsen Bu
Yan Bai
Kai Wang
Jiacheng Guo
Deliang Shen
Jinying Zhang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Cardiology
[2] Henan Province Key Laboratory of Cardiac Injury and Repair,Department of Orthopaedic Surgery
[3] University of Otago,undefined
来源：
BMC Cardiovascular Disorders | / 19卷
关键词：
Novel Oral anticoagulants; Non-valvular atrial fibrillation; Asian patients; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
    Dhamane, Amol D.
    Ferri, Mauricio
    Keshishian, Allison
    Russ, Cristina
    Atreja, Nipun
    Gutierrez, Cynthia
    Emir, Birol
    Yuce, Huseyin
    Di Fusco, Manuela
    ADVANCES IN THERAPY, 2023, 40 (03) : 887 - 902
  • [42] Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
    Amol D. Dhamane
    Mauricio Ferri
    Allison Keshishian
    Cristina Russ
    Nipun Atreja
    Cynthia Gutierrez
    Birol Emir
    Huseyin Yuce
    Manuela Di Fusco
    Advances in Therapy, 2023, 40 : 887 - 902
  • [43] Novel oral anticoagulants in non-valvular atrial fibrillation: How to improve its management in Spain
    Anguita, M.
    Davalos, A.
    Lopez de Sa, E.
    Mateo, J.
    Monreal, M.
    Oliva, J.
    Polo, J.
    MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (02): : 109 - 116
  • [44] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients Reply
    Balci, Kevser Gulcihan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05):
  • [45] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    Current Cardiology Reports, 2015, 17
  • [46] Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
    Birkinshaw, Alexander
    Fry, Christopher H.
    Fluck, David
    Sharma, Pankaj
    Han, Thang S.
    JRSM CARDIOVASCULAR DISEASE, 2020, 9
  • [47] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [48] Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
    Balci, Kevser Gulcihan
    Balci, Mustafa Mucahit
    Canpolat, Ugur
    Sen, Fatih
    Akboga, Mehmet K.
    Suleymanoglu, Muhammed
    Kuyumcu, Serdar
    Maden, Orhan
    Selcuk, Hatice
    Selcuk, Mehmet Timur
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (07): : 474 - 481
  • [49] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [50] Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China
    Xiang, Xiao
    Cao, Yaying
    Sun, Kexin
    Song, Jing
    Tian, Yaohua
    Yin, Qiongzhou
    Juan, Juan
    Hu, Yonghua
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 255 - 261
12345